# Cost-Efficient and Fast At-Line Assessment of Content and Uniformity in Low-Dose Dimdazenil Capsules Using Transmission Raman Spectroscopy

**Authors:** Xun Ma, Lianlian Shan, Shuangpeng Zhu, Zihan Zhu, Shuyu Lu, Mingzhe Xu, Lihui Yin

PMC · DOI: 10.3390/pharmaceutics18030298 · Pharmaceutics · 2026-02-27

## TL;DR

This study shows how transmission Raman spectroscopy can quickly and accurately assess low-dose drug capsules without sample preparation.

## Contribution

The paper introduces a novel TRS method for low-dose (~1.5% w/w) dimdazenil capsules, a concentration rarely studied in TRS literature.

## Key findings

- The TRS method achieved relative errors below 5.0% across all validation sets.
- The method required no sample preparation and took less than 150 seconds per capsule.
- The TRS method scored 0.86 on AGREEprep, indicating strong environmental benefits over HPLC.

## Abstract

Background/Objectives: Transmission Raman spectroscopy (TRS) is widely used for non-destructive quantification of solid dosage forms, yet most applications involve high-dose formulations (>5% w/w active pharmaceutical ingredient (API)). This study addresses the underexplored area of low-dose drug analysis by developing a TRS method for dimdazenil capsules containing only ~1.5% w/w API—a concentration rarely reported in the current TRS literature. Methods: A partial least squares (PLS) model was built using TRS spectra of dimdazenil capsules, with sample variability introduced via a design of experiments (DoE) approach. Model performance was validated against reference high-performance liquid chromatography (HPLC) data from independent samples and three commercial batches, incorporating specificity checks and greenness assessment via AGREEprep. Results: The TRS method achieved reliable variation assessment with acceptable accuracy, showing relative errors below 5.0% across all validation sets despite a minor systematic bias of ~−2.87%. Analysis required no sample preparation and took less than 150 s per capsule. Specificity was ensured by the unique 1628 cm−1 band of dimdazenil, with no interference from excipients confirmed by spectral examination and multivariate statistical methods. The method scored 0.86 on AGREEprep, highlighting its environmental superiority over HPLC. Conclusions: This work demonstrates that TRS can be reliably extended to low-dose solid dosage forms (~1.5% w/w), a concentration range rarely addressed in the existing TRS literature. This significantly broadens its applicability in pharmaceutical quality control and supports its potential integration into continuous manufacturing for challenging low-concentration products.

## Linked entities

- **Chemicals:** dimdazenil (PubChem CID 9885841)

## Full-text entities

- **Chemicals:** Dimdazenil (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028709/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028709/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028709/full.md

---
Source: https://tomesphere.com/paper/PMC13028709